COMPANY PROFILE

Ascribe Bioscience

Explore full profile

A company that develops natural crop protection based on small molecules in the soil microbiome.

Ithaca, United StatesFounded 2017Food

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Ascribe Bioscience

Ascribe Bioscience, founded in 2017 and based on discoveries at the Boyce Thompson Institute at Cornell University, develops natural crop protection products aimed at helping farmers reduce disease and increase yield without harming the environment or human health. The company operates in the agricultural biotechnology market, providing an alternative to toxic chemicals and expensive biologicals. Ascribe's products are based on naturally occurring small molecules from the soil microbiome and can be applied as seed treatments or foliar sprays. The primary clients are farmers looking for sustainable and effective crop protection solutions. Ascribe generates revenue through the sale of its crop protection products. The company has received a NSF SBIR grant, highlighting its innovative approach and potential impact on the agricultural sector.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Ithaca, United States
Employees: 14
Open positions: None listed
Dealroom signal: 87.1/100
Industry: Food, Chemicals
Sub-industry: AgriTech
Sector: Food, Biotechnology, Crop Protection, Microbiome, Sustainable Development Goals, Climate Tech, DT and LS, science-based
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Oct 2025	$12M	$48M	Cultivation Capital · The Yield Lab · Trailhead Capital · Acre Venture Partners	↗
EARLY VC✓Equity / VC	Feb 2025	$0	—	ICIG Ventures	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Ascribe Bioscience website traffic

Latest recorded traffic for Ascribe Bioscience is 3.8K monthly website visits, up 153.3% over the last three months. Ascribe Bioscience's team grew 27.3% over the past year.

Latest monthly visits3.8K 3-month web change+153.3% 1-year team growth+27.3%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CRCropBiomeInnovative microbiology for agriculture	Dublin, Ireland	Operational	4	$1.4M	$5.7M
REReGenMaking biological seed coatings that enhance soil health and crop performance using soil microbiomes	Gderot Regional Council, Israel	Operational
TATarvosRevolutionize Integrated Pest Management with our cutting-edge blend of science and technology for optimized pesticide use	Campinas, Brazil	Operational
TETerrameraUses technology to unlock the intelligence in nature to ensure an earth that thrives and provides for everyone	Vancouver, Canada	Operational
VEVestaronDedicated to improving the safety, efficacy, and sustainability of crop protection through migration from chemical pesticides to biological peptides	Kalamazoo, United States	Operational
BIBiocSolSpecializes in developing innovative microbial-free biopesticides empowering farmers with efficient biocontrol for crop protection	Ottignies-Louvain-la-Neuve, Belgium	Operational
MIMinagroBio-based ingredients improving crop protection and nutrition	Mont-Saint-Guibert, Belgium	Operational
LBLux BioEngineering bioluminescent proteins	Vancouver, Canada	Operational